Michael began his career at Coopers and Lybrand. He provides strategic leadership, management of the organization and the provision of oversight and support to the Operations and Finance staff. He is also responsible for the oversight and management of various project functions and services, including operations planning and management; contracts management, procurements; project administration; logistics and ensuring compliance with all necessary industry regulations. He provides administrative supervision to all operations and finance staff and oversee performance management.
He brings on board over 25 years of finance experience including over 17 years within the pharmaceutical industry at Alexion Pharmaceuticals, Bristol-Myers Squibb and Schering-Plough. He joined EAKIN HEALTHCARE LIMITED from Alexion Pharmaceuticals where he held position as an Executive Director, Finance for North & latin American Regions, providing financial leadership, strategy and investment planning for the regions including launching two simultaneous Orphan Drugs in the US.
Michael’s finance roles have spans various areas including strategic planning and analysis at the Corporate, Commercial and R&D levels, financial restructuring and M&A, handling international transactions.
Michael possesses strong foundation in financial accounting and internal controls.
He’s an alumnus of Stanford University’s School of Business where he earned Bachelor of Science degree in Accountancy amongst other international qualifications. He is also a Certified chartered and public accountant.